OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BioMerieux SA/  FR0013280286  /

Euronext - Paris
2024-04-19  12:41:25 PM Chg. -0.050 Volume Bid2024-04-19 Ask12:42:41 PM Market Capitalization Dividend Y. P/E Ratio
98.950EUR -0.05% 21,068
Turnover: 2.07 mill.		 98.800Bid Size: 183 98.950Ask Size: 149 11.71 bill.EUR 0.86% 32.66
GlobeNewswire 04-18 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 2023-12-04 Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire 2023-10-27 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 2023-09-20 Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed...
GlobeNewswire 2021-10-19 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 2021-10-05 Quotient Limited Announces Appointment of Chief Commercial Officer
GlobeNewswire 2021-10-04 Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire 2021-09-16 Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire 2021-06-01 Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire 2021-03-10 Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire 2021-02-23 Quotient Limited Announces Manuel Mendez as Chief Executive Officer
GlobeNewswire 2021-02-04 Berkeley Lights Announces CFO Transition and C-Level Additions
GlobeNewswire 2021-01-04 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire 2020-12-16 MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
GlobeNewswire 2020-12-07 Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
GlobeNewswire 2020-09-29 Synairgen plc - Interim results for the six months ended 30 June 2020
GlobeNewswire 2020-09-17 Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire 2020-07-15 DNV3837 antibiotic candidate: the Phase II trial continues in the US
GlobeNewswire 2020-06-15 T2 Biosystems Announces Changes to Board of Directors
GlobeNewswire 2020-05-04 Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
GlobeNewswire 2020-04-01 Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market...
GlobeNewswire 2020-03-18 Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar Fran...
GlobeNewswire 2020-03-11 DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance
GlobeNewswire 2020-02-19 DEINOVE expands its range of cosmetic active ingredients
GlobeNewswire 2020-02-06 Sharon Laboratories capitalizes on Deinove to sustain its development activities